<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:regn="http://regeneron.com/20231231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="regn-20231231.xsd" xlink:type="simple"/>
    <context id="From2023-01-01to2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForPEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForPEOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_InclusionOfItem402vEquityAwardValuesForPEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:InclusionOfItem402vEquityAwardValuesForPEOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForNonPEONEOsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForNonPEONEOsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_InclusionOfItem402vEquityAwardValuesForNonPEONEOsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:InclusionOfItem402vEquityAwardValuesForNonPEONEOsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForPEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:YearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForPEOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_ChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForPEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:ChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForPEOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_VestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForPEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:VestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForPEOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_ChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForPEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:ChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForPEOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_FairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForPEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:FairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForPEOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForPEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForPEOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_TotalInclusionOfEquityValuesForPEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:TotalInclusionOfEquityValuesForPEOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForNonPEONEOsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:AverageYearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForNonPEONEOsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForNonPEONEOsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:AverageChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForNonPEONEOsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageVestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForNonPEONEOsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:AverageVestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForNonPEONEOsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForNonPEONEOsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:AverageChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForNonPEONEOsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForNonPEONEOsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForNonPEONEOsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForNonPEONEOsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:AverageValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForNonPEONEOsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_TotalAverageInclusionOfEquityValuesForNonPEONEOsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">regn:TotalAverageInclusionOfEquityValuesForNonPEONEOsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>5</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>6</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>7</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000872589</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-01-01to2023-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-12-31" id="Fact000004">0000872589</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2023-01-01to2023-12-31" id="Fact000011">REGENERON PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000013">&lt;h4 id="xdx_80E_eecd--PvpTableTextBlock_dU_zHvIQwA4Qdwf" style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #D60058"&gt;&lt;b&gt;&lt;span id="lregna088"&gt;&lt;/span&gt;&lt;span id="lregnb039"&gt;&lt;/span&gt;Pay Versus Performance&lt;/b&gt;&lt;/h4&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #D60058"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;As required by Item 402(v) of Regulation S-K, the following table
and accompanying footnotes and discussion provide certain information regarding executive compensation and measures of Company
performance for the years presented. Except where expressly stated, the information presented below was not considered by the Compensation
Committee in structuring our executive compensation program for the years presented, and the reader should instead refer to the
section &#x201c;Compensation Discussion and Analysis&#x201d; for a description of the philosophy, objectives, and structure of our
pay&#160;program.&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30F_zI1NhSFx0ULh" style="font: 9pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; width: 2%; padding-bottom: 1pt; text-align: center; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; width: 9%; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; width: 4%; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="color: #215AA8"&gt;B&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; width: 9%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; width: 4%; text-align: center"&gt;&lt;span style="color: #215AA8"&gt;C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; width: 9%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; width: 5%; text-align: center"&gt;&lt;span style="color: #215AA8"&gt;D&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; width: 9%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; width: 5%; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="color: #215AA8"&gt;E&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; width: 9%; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; width: 3%; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="color: #215AA8"&gt;F&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; width: 3%; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; width: 3%; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="color: #215AA8"&gt;G&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; width: 9%; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; width: 4%; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="color: #215AA8"&gt;H&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; width: 9%; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; width: 4%; padding-bottom: 1pt; text-align: center; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="color: #215AA8"&gt;Value of Initial Fixed&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;$100 Investment&lt;/span&gt;&lt;br/&gt; &lt;span style="color: #215AA8"&gt;Based On:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-right: 3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: left; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Summary&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Table Total for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;PEO ($)&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;&#x201c;Actually Paid&#x201d; to&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;PEO ($)&lt;sup&gt;1,2,3&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Summary&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Compensation Table&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Total for Non-PEO&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;NEOs ($)&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;&#x201c;Actually Paid&#x201d; to&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;($)&lt;sup&gt;1,2,3&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;TSR ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Peer Group&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;TSR ($)&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Net Income ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Stock&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Price ($)&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--PeoTotalCompAmt_pp0p0_c20230101__20231231_fMQ_____zz4cwiA8QPfa" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="PEO Total Compensation Amount"&gt;8,184,338&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--PeoActuallyPaidCompAmt_pp0p0_c20230101__20231231_fMSAyIDM___zzh0pzp4R48i" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="PEO Total Compensation Amount"&gt;141,071,193&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20230101__20231231_fMQ_____zXVjvczwdIbl" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Non-PEO NEO Average Total Compensation Amount"&gt;6,713,442&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20230101__20231231_fMSAyIDM___zk4FZEP3fisg" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;46,896,425&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_zezAObxYHK93" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Total Shareholder Return Amount"&gt;233.91&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20230101__20231231_fNA_____zb3Mq3PFNiW3" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Peer Group Total Shareholder Return Amount"&gt;159.01&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--NetIncomeLoss_uUSD_c20230101__20231231_zSjSKje1e1C8" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Net Income (Loss)"&gt;3,953,600,000&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--CoSelectedMeasureAmt_uUSD_c20230101__20231231_fNQ_____zrqINUS3BwG4" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right; padding-right: 3pt" title="Company Selected Measure Amount"&gt;878.29&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #ECECED"&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--PeoTotalCompAmt_pp0p0_c20220101__20221231_fMQ_____zt0mROulG75a" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="PEO Total Compensation Amount"&gt;7,004,069&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--PeoActuallyPaidCompAmt_pp0p0_c20220101__20221231_fMSAyIDM___zzuFPdZlhSHl" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="PEO Total Compensation Amount"&gt;98,786,583&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20220101__20221231_fMQ_____zvM1juwd4PTl" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Non-PEO NEO Average Total Compensation Amount"&gt;8,061,639&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20220101__20221231_fMSAyIDM___z6eMfxgmg2tc" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;32,174,465&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_zGo4J0nu7Pc6" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Total Shareholder Return Amount"&gt;192.15&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20220101__20221231_fNA_____zrBTDrIi7cb" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Peer Group Total Shareholder Return Amount"&gt;153.08&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--NetIncomeLoss_uUSD_c20220101__20221231_zvpLorW3IhLe" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Net Income (Loss)"&gt;4,338,400,000&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--CoSelectedMeasureAmt_uUSD_c20220101__20221231_fNQ_____zbvlZHuOEEkd" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right; padding-right: 3pt" title="Company Selected Measure Amount"&gt;721.49&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--PeoTotalCompAmt_pp0p0_c20210101__20211231_fMQ_____zL4AkIEtbUmf" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="PEO Total Compensation Amount"&gt;6,470,514&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98B_eecd--PeoActuallyPaidCompAmt_pp0p0_c20210101__20211231_fMSAyIDM___zVsvL8BP8m58" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="PEO Total Compensation Amount"&gt;123,744,652&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20210101__20211231_fMQ_____zJwbgHWkQbu6" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Non-PEO NEO Average Total Compensation Amount"&gt;7,548,928&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20210101__20211231_fMSAyIDM___zMLWfw6zx5Lk" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;40,168,860&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--TotalShareholderRtnAmt_pp2p0_c20210101__20211231_zT0KgGpkrhrg" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Total Shareholder Return Amount"&gt;168.19&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20210101__20211231_fNA_____zTQtNPRgxs12" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Peer Group Total Shareholder Return Amount"&gt;137.47&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_uUSD_c20210101__20211231_zprJrLZQ4kEk" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right" title="Net Income (Loss)"&gt;8,075,300,000&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--CoSelectedMeasureAmt_uUSD_c20210101__20211231_fNQ_____zqUPiM9whkoa" style="border-bottom: rgb(148,149,153) 1px solid; vertical-align: bottom; text-align: right; padding-right: 3pt" title="Company Selected Measure Amount"&gt;631.52&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: #ECECED"&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2020&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--PeoTotalCompAmt_pp0p0_c20200101__20201231_fMQ_____ztppgGImUHA2" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right" title="PEO Total Compensation Amount"&gt;135,350,121&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--PeoActuallyPaidCompAmt_pp0p0_c20200101__20201231_fMSAyIDM___z0OwaxSMvd94" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right" title="PEO Total Compensation Amount"&gt;153,035,522&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20200101__20201231_fMQ_____zRqh3xabpPZ4" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right" title="Non-PEO NEO Average Total Compensation Amount"&gt;40,058,597&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20200101__20201231_fMSAyIDM___zJSYcUQiyGvf" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;48,557,559&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--TotalShareholderRtnAmt_pp2p0_c20200101__20201231_zDwYEU3gTP34" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right" title="Total Shareholder Return Amount"&gt;128.66&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--PeerGroupTotalShareholderRtnAmt_pp2p0_c20200101__20201231_fNA_____zGlhEBXKlED8" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right" title="Peer Group Total Shareholder Return Amount"&gt;110.52&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--NetIncomeLoss_uUSD_c20200101__20201231_zKk1VQfDEBjb" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right" title="Net Income (Loss)"&gt;3,513,200,000&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--CoSelectedMeasureAmt_uUSD_c20200101__20201231_fNQ_____z5UZGmasUIx3" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt" title="Company Selected Measure Amount"&gt;483.11&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-top: 3pt; width: 18pt"&gt;&lt;sup id="xdx_F0B_zp9zxoRSRJU9" style="display: none; visibility: hidden"&gt;1&lt;/sup&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_zCE0BETisq09" style="display: none; padding-top: 3pt; visibility: hidden"&gt;Leonard S. Schleifer, M.D., Ph.D. was our principal executive officer (&#x201c;PEO&#x201d;)
    for each year presented. George D. Yancopoulos, M.D., Ph.D., Robert E. Landry, Daniel P. Van Plew, and Andrew J. Murphy, Ph.D.
    comprise the non-PEO named executive officers (&#x201c;Non-PEO NEOs&#x201d;) for 2020 and 2023; and each of these individuals
    plus Joseph J. LaRosa and Marion McCourt comprise the Non-PEO NEOs for 2021 and 2022, respectively.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td style="display: none; padding-top: 3pt; visibility: hidden"&gt;&lt;sup id="xdx_F09_z1Cek9x3Bie8" style="display: none; visibility: hidden"&gt;2&lt;/sup&gt;&lt;/td&gt;
    &lt;td id="xdx_F11_zLehpKzm1BBb" style="display: none; padding-top: 3pt; visibility: hidden"&gt;The amounts shown for &#x201c;Compensation &#x201c;Actually Paid&#x201d;&#x201d; have been calculated
    in accordance with Item 402(v) of Regulation S K and do not reflect compensation actually earned, realized, or received by
    the Company&#x2019;s NEOs. These amounts reflect total compensation as reported in the Summary Compensation Table with certain
    adjustments as described in footnote 3 below.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td id="xdx_F03_zOiPj04YxKIk" style="display: none; padding-top: 3pt; visibility: hidden"&gt;&lt;sup style="display: none; visibility: hidden"&gt;3&lt;/sup&gt;&lt;/td&gt;
    &lt;td id="xdx_F1F_zVBHXsmmOjwl" style="display: none; padding-top: 3pt; visibility: hidden"&gt;&#x201c;Compensation &#x201c;Actually Paid&#x201d;&#x201d; reflects the exclusions and inclusions
    of equity awards for the PEO and the Non-PEO NEOs as set forth below and calculated in accordance with FASB ASC Topic 718
    using the valuation methodologies and assumptions set forth in the calculation of the grant date fair value of these awards
    as disclosed in the Company&#x2019;s audited financial statements for the fiscal year in which the equity awards were
    granted.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; display: none; width: 100%; border-collapse: collapse; visibility: hidden"&gt;
&lt;tr style="display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td style="display: none; padding-top: 3pt; width: 18pt; visibility: hidden"&gt;&#160;&lt;/td&gt;
    &lt;td style="display: none; padding-top: 3pt; visibility: hidden"&gt;The &#x201c;Exclusion of Stock Awards and Option Awards from Summary Compensation Table&#x201d;
    columns in the tables below reflect the aggregate amounts reported in the Summary Compensation Table for the applicable year
    in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; display: none; width: 100%; border-collapse: collapse; visibility: hidden"&gt;
&lt;tr style="display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td style="display: none; padding-top: 3pt; width: 18pt; visibility: hidden"&gt;&lt;sup id="xdx_F0B_zDVm5p643VYk" style="display: none; visibility: hidden"&gt;4&lt;/sup&gt;&lt;/td&gt;
    &lt;td id="xdx_F1F_zPJgKGD6djKa" style="display: none; padding-top: 3pt; visibility: hidden"&gt;The Peer Group TSR shown in this table utilizes the NASDAQ US Benchmark Pharmaceuticals
    Total Return Index (&#x201c;NQ US Pharma Index&#x201d;), which we also utilized in the stock performance graph required by Item
    201(e) of Regulation S-K included in our Annual Reports on Form 10-K for the years reflected in the table above. The comparison
    assumes $100 was invested for the period starting December 31, 2019 through December 31 of the applicable fiscal year in each
    of the Company&#x2019;s common stock and the NQ US Pharma Index. All dollar values assume reinvestment of the pre-tax value
    of dividends paid by companies included in the NQ US Pharma Index. The historical stock price performance of our common stock
    shown is not necessarily indicative of future stock price performance.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; visibility: hidden"&gt;
    &lt;td style="display: none; padding-top: 3pt; visibility: hidden"&gt;&lt;sup id="xdx_F00_zi46Mae6l7k1" style="display: none; visibility: hidden"&gt;5&lt;/sup&gt;&lt;/td&gt;
    &lt;td id="xdx_F19_zBOdTmRk3XVh" style="display: none; padding-top: 3pt; visibility: hidden"&gt;Pursuant to Item 402(v) of Regulation S-K, we determined our stock price to be the most important
    financial performance measure used to link Company performance to Compensation &#x201c;Actually Paid&#x201d; to our PEO and
    other NEOs in 2023. This performance measure may not have been the most important financial performance measure for prior
    years and we may determine a different financial performance measure to be the most important such measure in future years.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_842_eecd--NamedExecutiveOfficersFnTextBlock_zCOUcqeJnX8h" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 18pt; padding-top: 3pt"&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&lt;span id="xdx_905_eecd--PeoName_c20230101__20231231_zNOHhcSSbcHc"&gt;&lt;span id="xdx_901_eecd--PeoName_c20220101__20221231_ze1olnLpWxj6"&gt;&lt;span id="xdx_903_eecd--PeoName_c20210101__20211231_zKqfqUDQ6Qi9"&gt;&lt;span id="xdx_90E_eecd--PeoName_c20200101__20201231_zqXcfPEChiD3"&gt;Leonard S. Schleifer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;, M.D., Ph.D. was our principal executive officer (&#x201c;PEO&#x201d;)
    for each year presented. George D. Yancopoulos, M.D., Ph.D., Robert E. Landry, Daniel P. Van Plew, and Andrew J. Murphy, Ph.D.
    comprise the non-PEO named executive officers (&#x201c;Non-PEO NEOs&#x201d;) for 2020 and 2023; and each of these individuals
    plus Joseph J. LaRosa and Marion McCourt comprise the Non-PEO NEOs for 2021 and 2022, respectively.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_85C_zStlnpaV4Gqg" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-top: 3pt; width: 18pt"&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;The amounts shown for &#x201c;Compensation &#x201c;Actually Paid&#x201d;&#x201d; have been calculated
    in accordance with Item 402(v) of Regulation S K and do not reflect compensation actually earned, realized, or received by
    the Company&#x2019;s NEOs. These amounts reflect total compensation as reported in the Summary Compensation Table with certain
    adjustments as described in footnote 3 below.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-top: 3pt"&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&#x201c;Compensation &#x201c;Actually Paid&#x201d;&#x201d; reflects the exclusions and inclusions
    of equity awards for the PEO and the Non-PEO NEOs as set forth below and calculated in accordance with FASB ASC Topic 718
    using the valuation methodologies and assumptions set forth in the calculation of the grant date fair value of these awards
    as disclosed in the Company&#x2019;s audited financial statements for the fiscal year in which the equity awards were
    granted.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-top: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;The &#x201c;Exclusion of Stock Awards and Option Awards from Summary Compensation Table&#x201d;
    columns in the tables below reflect the aggregate amounts reported in the Summary Compensation Table for the applicable year
    in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_84D_eecd--AdjToPeoCompFnTextBlock_dU_gL2ATPCFTB-ZNHISU_zHwzs7nqZIBg" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_308_zettrqKs8ERl" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr&gt;
    &lt;td style="width: 18pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 2%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 18%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Summary Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Table Total for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 2%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 18%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Exclusion of Stock Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;and Option Awards from&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Summary Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Table for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 2%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 14%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Inclusion of Item 402(v)&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Award Values for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 2%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 14%; text-align: right; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Compensation &#x201c;Actually&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Paid&#x201d; to PEO ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--PeoTotalCompAmt_c20230101__20231231_zBYK6oHgOabd" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;8,184,338&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForPEOMember_fKGEp_zK9X3Hk8Y4j5" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--InclusionOfItem402vEquityAwardValuesForPEOMember_fKGEp_zf9Utyuub5Bh" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;132,886,855&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_z8aTYBOxXBj9" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;141,071,193&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;

&lt;p id="xdx_85C_zc8U5sMZMJS7" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_gL2ATNPNCFTB-EUEKM_zux2XGdxdq9" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30811_zettrqKs8ERl" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr&gt;
    &lt;td style="width: 18pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 18%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 18%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 14%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; padding-right: 3pt; width: 14%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Summary&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Compensation Table Total for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Exclusion of Stock Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;and Option Awards from&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Summary Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Table for Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Inclusion of Item 402(v)&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Award Values for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Average Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;&#x201c;Actually Paid&#x201d; to&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zH7Dx6gimRni" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;6,713,442&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForNonPEONEOsMember_fKGEp_zEkI5CQ2sSJh" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;(3,374,461)&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--InclusionOfItem402vEquityAwardValuesForNonPEONEOsMember_fKGEp_zogS42O9yBb4" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;43,557,444&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zjOKRGf5qAI2" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;46,896,425&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_85B_zkjF9GwNMqCg" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;


    &lt;div style="border-bottom: Silver 4px solid; margin-bottom: 6pt"&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%"&gt;&lt;tr&gt;&lt;td style="text-align: center; width: 100%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
    &lt;div style="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"&gt;&lt;/div&gt;


&lt;p style="font: 20pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 18pt"&gt;The &#x201c;Inclusion of Item 402(v) Equity Award Values&#x201d;
columns in the tables above are derived from the dollar values set forth in the following tables:&lt;/p&gt;

&lt;div id="xdx_C0D_gL2ATPCFTB-ZNHISU_zWTM9XeHQKaa"&gt;&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_zdYcRYtY8rz1" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 18pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 15%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Year-End Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value of Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards Granted&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;During Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;That Remained&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Unvested as of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Last Day of Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Change in Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value from Last&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Day of Prior Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;to Last Day of Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Unvested Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Vesting-Date Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value of Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards Granted&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;During Year that&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Vested During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Change in Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value from Last&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Day of Prior Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;to Vesting Date of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Unvested Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards that&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Vested During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Fair Value at Last&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Day of Prior Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Equity Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Forfeited During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Value of Dividends&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;or Other Earnings&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Paid on Stock or&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Option Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Not Otherwise&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Included&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Total - Inclusion&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Equity Values&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;for PEO ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForPEOMember_fKGEp_zMqiHevLwNBg" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForPEOMember_fKGEp_zBs0wBwfn3Uk" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;126,245,090&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--VestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForPEOMember_fKGEp_zHHY0C6XRVY7" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForPEOMember_fKGEp_zcz3H72u4bo9" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;6,641,765&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--FairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForPEOMember_fKGEp_zqwxdDioyYmj" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForPEOMember_fKGEp_zqHNXaIOoa5a" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalInclusionOfEquityValuesForPEOMember_fKGEp_z8a1Zvl3X1s9" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;132,886,855&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;
&lt;/div&gt;
&lt;div id="xdx_C01_gL2ATNPNCFTB-EUEKM_zj0uLuoBvthg"&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="font-size: 12pt"&gt;
    &lt;td style="font-size: 12pt; width: 18pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 3pt; font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 15%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; padding-right: 3pt; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year-End Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value of Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards Granted&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;During Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;That Remained&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Unvested as of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Last Day of Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;for Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Change&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;in Fair Value from&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Last Day of Prior&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year to Last Day of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year of Unvested&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Awards for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Vesting-&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Date Fair Value&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Equity Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Granted During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year that Vested&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;During Year for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Change&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;in Fair Value from&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Last Day of Prior&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year to Vesting&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Date of Unvested&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;that Vested During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for Non-PEO&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value at Last Day&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Prior Year of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Forfeited During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for Non-PEO&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Value&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Dividends or&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Other Earnings&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Paid on Stock or&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Option Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Not Otherwise&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Included for Non-&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Total&#x2014;Average&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Inclusion of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Values for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForNonPEONEOsMember_fKGEp_zIz3TebNYMqg" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;3,521,007&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForNonPEONEOsMember_fKGEp_z3Xexy894ne2" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;34,981,296&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageVestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForNonPEONEOsMember_fKGEp_zqHmRYfNiC1d" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForNonPEONEOsMember_fKGEp_zxgBctHV3ndh" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;5,055,141&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForNonPEONEOsMember_fKGEp_zTs5BkNzDt56" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForNonPEONEOsMember_fKGEp_zRZGUddfe2K8" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAverageInclusionOfEquityValuesForNonPEONEOsMember_fKGEp_zPisA0Svrtt4" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;43,557,444&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;p id="xdx_843_eecd--PeerGroupIssuersFnTextBlock_z22NTA8ztLwi" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 18pt; padding-top: 3pt"&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;The Peer Group TSR shown in this table utilizes the NASDAQ US Benchmark Pharmaceuticals
    Total Return Index (&#x201c;NQ US Pharma Index&#x201d;), which we also utilized in the stock performance graph required by Item
    201(e) of Regulation S-K included in our Annual Reports on Form 10-K for the years reflected in the table above. The comparison
    assumes $100 was invested for the period starting December 31, 2019 through December 31 of the applicable fiscal year in each
    of the Company&#x2019;s common stock and the NQ US Pharma Index. All dollar values assume reinvestment of the pre-tax value
    of dividends paid by companies included in the NQ US Pharma Index. The historical stock price performance of our common stock
    shown is not necessarily indicative of future stock price performance.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_85F_z9NAg0ibXhFa" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-top: 3pt; width: 18pt"&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;Pursuant to Item 402(v) of Regulation S-K, we determined our &lt;span id="xdx_90E_eecd--CoSelectedMeasureName_c20230101__20231231_z1h7BllQBQB4"&gt;stock price&lt;/span&gt; to be the most important
    financial performance measure used to link Company performance to Compensation &#x201c;Actually Paid&#x201d; to our PEO and
    other NEOs in 2023. This performance measure may not have been the most important financial performance measure for prior
    years and we may determine a different financial performance measure to be the most important such measure in future years.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000015"
      unitRef="USD">8184338</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000017"
      unitRef="USD">141071193</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000019"
      unitRef="USD">6713442</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000021"
      unitRef="USD">46896425</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="2"
      id="Fact000023"
      unitRef="USD">233.91</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="2"
      id="Fact000025"
      unitRef="USD">159.01</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000027"
      unitRef="USD">3953600000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="INF"
      id="Fact000029"
      unitRef="USD">878.29</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000031"
      unitRef="USD">7004069</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000033"
      unitRef="USD">98786583</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000035"
      unitRef="USD">8061639</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000037"
      unitRef="USD">32174465</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="2"
      id="Fact000039"
      unitRef="USD">192.15</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="2"
      id="Fact000041"
      unitRef="USD">153.08</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000043"
      unitRef="USD">4338400000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact000045"
      unitRef="USD">721.49</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000047"
      unitRef="USD">6470514</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000049"
      unitRef="USD">123744652</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000051"
      unitRef="USD">7548928</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">40168860</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2021-01-012021-12-31"
      decimals="2"
      id="Fact000055"
      unitRef="USD">168.19</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2021-01-012021-12-31"
      decimals="2"
      id="Fact000057"
      unitRef="USD">137.47</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact000059"
      unitRef="USD">8075300000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact000061"
      unitRef="USD">631.52</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000063"
      unitRef="USD">135350121</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">153035522</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000067"
      unitRef="USD">40058597</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000069"
      unitRef="USD">48557559</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2020-01-012020-12-31"
      decimals="2"
      id="Fact000071"
      unitRef="USD">128.66</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt
      contextRef="From2020-01-012020-12-31"
      decimals="2"
      id="Fact000073"
      unitRef="USD">110.52</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact000075"
      unitRef="USD">3513200000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      id="Fact000077"
      unitRef="USD">483.11</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000084">&lt;p id="xdx_842_eecd--NamedExecutiveOfficersFnTextBlock_zCOUcqeJnX8h" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 18pt; padding-top: 3pt"&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;&lt;span id="xdx_905_eecd--PeoName_c20230101__20231231_zNOHhcSSbcHc"&gt;&lt;span id="xdx_901_eecd--PeoName_c20220101__20221231_ze1olnLpWxj6"&gt;&lt;span id="xdx_903_eecd--PeoName_c20210101__20211231_zKqfqUDQ6Qi9"&gt;&lt;span id="xdx_90E_eecd--PeoName_c20200101__20201231_zqXcfPEChiD3"&gt;Leonard S. Schleifer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;, M.D., Ph.D. was our principal executive officer (&#x201c;PEO&#x201d;)
    for each year presented. George D. Yancopoulos, M.D., Ph.D., Robert E. Landry, Daniel P. Van Plew, and Andrew J. Murphy, Ph.D.
    comprise the non-PEO named executive officers (&#x201c;Non-PEO NEOs&#x201d;) for 2020 and 2023; and each of these individuals
    plus Joseph J. LaRosa and Marion McCourt comprise the Non-PEO NEOs for 2021 and 2022, respectively.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2023-01-01to2023-12-31" id="Fact000085">Leonard S. Schleifer</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-01-012022-12-31" id="Fact000086">Leonard S. Schleifer</ecd:PeoName>
    <ecd:PeoName contextRef="From2021-01-012021-12-31" id="Fact000087">Leonard S. Schleifer</ecd:PeoName>
    <ecd:PeoName contextRef="From2020-01-012020-12-31" id="Fact000088">Leonard S. Schleifer</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000091">&lt;p id="xdx_84D_eecd--AdjToPeoCompFnTextBlock_dU_gL2ATPCFTB-ZNHISU_zHwzs7nqZIBg" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_308_zettrqKs8ERl" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr&gt;
    &lt;td style="width: 18pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 2%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 18%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Summary Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Table Total for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 2%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 18%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Exclusion of Stock Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;and Option Awards from&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Summary Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Table for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 2%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 14%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Inclusion of Item 402(v)&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Award Values for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 2%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 14%; text-align: right; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Compensation &#x201c;Actually&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Paid&#x201d; to PEO ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--PeoTotalCompAmt_c20230101__20231231_zBYK6oHgOabd" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;8,184,338&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForPEOMember_fKGEp_zK9X3Hk8Y4j5" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--InclusionOfItem402vEquityAwardValuesForPEOMember_fKGEp_zf9Utyuub5Bh" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;132,886,855&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_z8aTYBOxXBj9" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;141,071,193&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_308_zdYcRYtY8rz1" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 18pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 15%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Year-End Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value of Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards Granted&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;During Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;That Remained&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Unvested as of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Last Day of Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Change in Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value from Last&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Day of Prior Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;to Last Day of Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Unvested Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Vesting-Date Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value of Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards Granted&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;During Year that&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Vested During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Change in Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value from Last&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Day of Prior Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;to Vesting Date of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Unvested Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards that&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Vested During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Fair Value at Last&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Day of Prior Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Equity Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Forfeited During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Value of Dividends&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;or Other Earnings&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Paid on Stock or&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Option Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Not Otherwise&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Included&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;for PEO ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; width: 1%; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; width: 10%; text-align: right; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Total - Inclusion&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Equity Values&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;for PEO ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForPEOMember_fKGEp_zMqiHevLwNBg" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForPEOMember_fKGEp_zBs0wBwfn3Uk" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;126,245,090&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--VestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForPEOMember_fKGEp_zHHY0C6XRVY7" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForPEOMember_fKGEp_zcz3H72u4bo9" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;6,641,765&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--FairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForPEOMember_fKGEp_zqwxdDioyYmj" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForPEOMember_fKGEp_zqHNXaIOoa5a" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--TotalInclusionOfEquityValuesForPEOMember_fKGEp_z8a1Zvl3X1s9" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;132,886,855&lt;/td&gt;&lt;/tr&gt;

&lt;/table&gt;
</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000092"
      unitRef="USD">8184338</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForPEOMember"
      decimals="0"
      id="Fact000093"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_InclusionOfItem402vEquityAwardValuesForPEOMember"
      decimals="0"
      id="Fact000094"
      unitRef="USD">132886855</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000095"
      unitRef="USD">141071193</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000098">&lt;p id="xdx_845_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_gL2ATNPNCFTB-EUEKM_zux2XGdxdq9" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_30811_zettrqKs8ERl" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr&gt;
    &lt;td style="width: 18pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 3pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 18%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 18%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 14%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; padding-right: 3pt; width: 14%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Summary&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Compensation Table Total for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Exclusion of Stock Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;and Option Awards from&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Summary Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Table for Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Inclusion of Item 402(v)&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Award Values for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Average Compensation&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;&#x201c;Actually Paid&#x201d; to&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zH7Dx6gimRni" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;6,713,442&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForNonPEONEOsMember_fKGEp_zEkI5CQ2sSJh" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;(3,374,461)&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--InclusionOfItem402vEquityAwardValuesForNonPEONEOsMember_fKGEp_zogS42O9yBb4" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;43,557,444&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zjOKRGf5qAI2" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;46,896,425&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="font-size: 12pt"&gt;
    &lt;td style="font-size: 12pt; width: 18pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 3pt; font-size: 12pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 15%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; font-size: 12pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; padding-right: 3pt; font-size: 12pt; width: 10%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="white-space: nowrap"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year-End Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value of Equity&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Awards Granted&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;During Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;That Remained&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Unvested as of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Last Day of Year&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;for Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Change&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;in Fair Value from&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Last Day of Prior&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year to Last Day of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year of Unvested&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Awards for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Vesting-&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Date Fair Value&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Equity Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Granted During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year that Vested&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;During Year for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Change&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;in Fair Value from&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Last Day of Prior&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year to Vesting&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Date of Unvested&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;that Vested During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for Non-PEO&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Fair&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Value at Last Day&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Prior Year of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Forfeited During&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Year for Non-PEO&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right"&gt;&lt;span style="color: #215AA8"&gt;Average Value&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;of Dividends or&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Other Earnings&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Paid on Stock or&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Option Awards&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Not Otherwise&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Included for Non-&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; white-space: nowrap; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;&lt;span style="color: #215AA8"&gt;Total&#x2014;Average&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Inclusion of&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Equity Values for&lt;/span&gt;&lt;br/&gt;
    &lt;span style="color: #215AA8"&gt;Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; padding-left: 3pt"&gt;&lt;span style="color: #215AA8"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForNonPEONEOsMember_fKGEp_zIz3TebNYMqg" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;3,521,007&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForNonPEONEOsMember_fKGEp_z3Xexy894ne2" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;34,981,296&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageVestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForNonPEONEOsMember_fKGEp_zqHmRYfNiC1d" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForNonPEONEOsMember_fKGEp_zxgBctHV3ndh" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;5,055,141&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForNonPEONEOsMember_fKGEp_zTs5BkNzDt56" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--AverageValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForNonPEONEOsMember_fKGEp_zRZGUddfe2K8" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right"&gt;0&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__custom--TotalAverageInclusionOfEquityValuesForNonPEONEOsMember_fKGEp_zPisA0Svrtt4" style="border-bottom: rgb(33,90,168) 2px solid; vertical-align: bottom; text-align: right; padding-right: 3pt"&gt;43,557,444&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000099"
      unitRef="USD">6713442</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ExclusionOfStockAwardsAndOptionAwardsFromSummaryCompensationTableForNonPEONEOsMember"
      decimals="0"
      id="Fact000100"
      unitRef="USD">-3374461</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_InclusionOfItem402vEquityAwardValuesForNonPEONEOsMember"
      decimals="0"
      id="Fact000101"
      unitRef="USD">43557444</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000102"
      unitRef="USD">46896425</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForPEOMember"
      decimals="0"
      id="Fact000106"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_ChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForPEOMember"
      decimals="0"
      id="Fact000107"
      unitRef="USD">126245090</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_VestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForPEOMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_ChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForPEOMember"
      decimals="0"
      id="Fact000109"
      unitRef="USD">6641765</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_FairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForPEOMember"
      decimals="0"
      id="Fact000110"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_ValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForPEOMember"
      decimals="0"
      id="Fact000111"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_TotalInclusionOfEquityValuesForPEOMember"
      decimals="0"
      id="Fact000112"
      unitRef="USD">132886855</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringYearThatRemainedUnvestedAsOfLastDayOfYearForNonPEONEOsMember"
      decimals="0"
      id="Fact000113"
      unitRef="USD">3521007</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageChangeInFairValueFromLastDayOfPriorYearToLastDayOfYearOfUnvestedEquityAwardsForNonPEONEOsMember"
      decimals="0"
      id="Fact000114"
      unitRef="USD">34981296</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageVestingDateFairValueOfEquityAwardsGrantedDuringYearThatVestedDuringYearForNonPEONEOsMember"
      decimals="0"
      id="Fact000115"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageChangeInFairValueFromLastDayOfPriorYearToVestingDateOfUnvestedEquityAwardsThatVestedDuringYearForNonPEONEOsMember"
      decimals="0"
      id="Fact000116"
      unitRef="USD">5055141</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_AverageFairValueAtLastDayOfPriorYearOfEquityAwardsForfeitedDuringYearForNonPEONEOsMember"
      decimals="0"
      id="Fact000117"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_custom_AverageValueOfDividendsOrOtherEarningsPaidOnStockOrOptionAwardsNotOtherwiseIncludedForNonPEONEOsMember"
      decimals="0"
      id="Fact000118"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_TotalAverageInclusionOfEquityValuesForNonPEONEOsMember"
      decimals="0"
      id="Fact000119"
      unitRef="USD">43557444</ecd:AdjToCompAmt>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000121">&lt;p id="xdx_843_eecd--PeerGroupIssuersFnTextBlock_z22NTA8ztLwi" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 18pt; padding-top: 3pt"&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-top: 3pt"&gt;The Peer Group TSR shown in this table utilizes the NASDAQ US Benchmark Pharmaceuticals
    Total Return Index (&#x201c;NQ US Pharma Index&#x201d;), which we also utilized in the stock performance graph required by Item
    201(e) of Regulation S-K included in our Annual Reports on Form 10-K for the years reflected in the table above. The comparison
    assumes $100 was invested for the period starting December 31, 2019 through December 31 of the applicable fiscal year in each
    of the Company&#x2019;s common stock and the NQ US Pharma Index. All dollar values assume reinvestment of the pre-tax value
    of dividends paid by companies included in the NQ US Pharma Index. The historical stock price performance of our common stock
    shown is not necessarily indicative of future stock price performance.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:CoSelectedMeasureName contextRef="From2023-01-01to2023-12-31" id="Fact000122">stock price</ecd:CoSelectedMeasureName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000124">&lt;p id="xdx_800_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zEgUDwgAjDd8" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&lt;b&gt;PEO and Average Non-PEO
NEO Compensation &#x201c;Actually Paid&#x201d; Versus Regeneron TSR, 2020-2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&lt;img alt="" src="lregnx107x1.jpg"/&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000126">&lt;p id="xdx_80B_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_z6xylTEmHZGb" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&lt;b&gt;PEO and Average NEO Compensation
&#x201c;Actually Paid&#x201d; Versus Regeneron Net Income, 2020-2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&lt;img alt="" src="lregnx108x1.jpg"/&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000128">&lt;p id="xdx_805_eecd--CompActuallyPaidVsCoSelectedMeasureTextBlock_dU_zAIBmgTQaxw5" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&lt;b&gt;PEO and Average Non-PEO
NEO Compensation &#x201c;Actually Paid&#x201d; Versus Regeneron Stock Price, 2020-2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #215AA8"&gt;&lt;img alt="" src="lregnx108x2.jpg"/&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000130">&lt;p id="xdx_801_eecd--TotalShareholderRtnVsPeerGroupTextBlock_dU_zP2cyA7ixeg6" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&lt;b&gt;Comparison of Regeneron
Cumulative TSR to the NQ US Pharma Total Return Index, 2020-2023&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #215AA8"&gt;&lt;img alt="" src="lregnx109x1.jpg"/&gt;&lt;/p&gt;

</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:TabularListTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000132">&lt;h5 id="xdx_80C_eecd--TabularListTableTextBlock_dU_zaKFkA2MTKFk" style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #215AA8"&gt;&lt;b&gt;2023 Tabular List of Most Important Financial
and Non-Financial Performance Measures&lt;/b&gt;&lt;/h5&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #215AA8"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;The following table presents the financial and non-financial performance
measures that the Company considers to have been the most important in linking Compensation &#x201c;Actually Paid&#x201d; to our
PEO and our Non-PEO NEOs in 2023 to Company performance. The measures in this table are not ranked.&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: rgb(33,90,168) 2px solid; width: 55%; border-bottom: rgb(148,149,153) 1px solid; padding-left: 3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_903_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__1_zgwMmZqoEScb"&gt;Stock Price&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: rgb(33,90,168) 2px solid; width: 45%; border-bottom: rgb(148,149,153) 1px solid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__5_zbnKkpY3Jald"&gt;Regulatory submissions for new products or indications&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #ECECED"&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; padding-left: 3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_906_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__2_znJmyWeSv5tl"&gt;TSR&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90D_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__6_zbs93eERqlAe"&gt;Positive data readouts&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid; padding-left: 3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90F_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__3_zP40seWci0Ph"&gt;Non-GAAP diluted EPS&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(148,149,153) 1px solid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_90A_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__7_zanKjIrg2bI7"&gt;New Investigational New Drug Applications&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: #ECECED"&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid; padding-left: 3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFBheSB2cyBQZXJmb3JtYW5jZSBEaXNjbG9zdXJlAA__" id="xdx_905_eecd--MeasureName_c20230101__20231231__ecd--MeasureAxis__4_z58BxHD9Wf83"&gt;Approvals of new products or indications&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: rgb(33,90,168) 2px solid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_1" id="Fact000133">Stock Price</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_5" id="Fact000134">Regulatory submissions for new products or indications</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_2" id="Fact000135">TSR</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_6" id="Fact000136">Positive data readouts</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_3" id="Fact000137">Non-GAAP diluted EPS</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_7" id="Fact000138">New Investigational New Drug Applications</ecd:MeasureName>
    <ecd:MeasureName contextRef="From2023-01-012023-12-31_4" id="Fact000139">Approvals of new products or indications</ecd:MeasureName>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000015"
          xlink:label="Fact000015"
          xlink:type="locator"/>
        <link:footnote id="Footnote000078" xlink:label="Footnote000078" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Leonard S. Schleifer, M.D., Ph.D. was our principal executive officer (&#x201c;PEO&#x201d;)
    for each year presented. George D. Yancopoulos, M.D., Ph.D., Robert E. Landry, Daniel P. Van Plew, and Andrew J. Murphy, Ph.D.
    comprise the non-PEO named executive officers (&#x201c;Non-PEO NEOs&#x201d;) for 2020 and 2023; and each of these individuals
    plus Joseph J. LaRosa and Marion McCourt comprise the Non-PEO NEOs for 2021 and 2022, respectively.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000015"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000079" xlink:label="Footnote000079" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts shown for &#x201c;Compensation &#x201c;Actually Paid&#x201d;&#x201d; have been calculated
    in accordance with Item 402(v) of Regulation S K and do not reflect compensation actually earned, realized, or received by
    the Company&#x2019;s NEOs. These amounts reflect total compensation as reported in the Summary Compensation Table with certain
    adjustments as described in footnote 3 below.</link:footnote>
        <link:footnote id="Footnote000080" xlink:label="Footnote000080" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">&#x201c;Compensation &#x201c;Actually Paid&#x201d;&#x201d; reflects the exclusions and inclusions
    of equity awards for the PEO and the Non-PEO NEOs as set forth below and calculated in accordance with FASB ASC Topic 718
    using the valuation methodologies and assumptions set forth in the calculation of the grant date fair value of these awards
    as disclosed in the Company&#x2019;s audited financial statements for the fiscal year in which the equity awards were
    granted.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000079"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000080"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000079"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000080"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000079"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000080"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000035"
          xlink:label="Fact000035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000037"
          xlink:label="Fact000037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000079"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000080"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000047"
          xlink:label="Fact000047"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000047"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000049"
          xlink:label="Fact000049"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000049"
          xlink:to="Footnote000079"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000049"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000049"
          xlink:to="Footnote000080"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000051"
          xlink:label="Fact000051"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000051"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000053"
          xlink:label="Fact000053"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000053"
          xlink:to="Footnote000079"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000053"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000053"
          xlink:to="Footnote000080"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000063"
          xlink:label="Fact000063"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000063"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000065"
          xlink:label="Fact000065"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000065"
          xlink:to="Footnote000079"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000065"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000065"
          xlink:to="Footnote000080"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000067"
          xlink:label="Fact000067"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000067"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000069"
          xlink:label="Fact000069"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000069"
          xlink:to="Footnote000079"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000069"
          xlink:to="Footnote000078"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000069"
          xlink:to="Footnote000080"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnote id="Footnote000081" xlink:label="Footnote000081" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Peer Group TSR shown in this table utilizes the NASDAQ US Benchmark Pharmaceuticals
    Total Return Index (&#x201c;NQ US Pharma Index&#x201d;), which we also utilized in the stock performance graph required by Item
    201(e) of Regulation S-K included in our Annual Reports on Form 10-K for the years reflected in the table above. The comparison
    assumes $100 was invested for the period starting December 31, 2019 through December 31 of the applicable fiscal year in each
    of the Company&#x2019;s common stock and the NQ US Pharma Index. All dollar values assume reinvestment of the pre-tax value
    of dividends paid by companies included in the NQ US Pharma Index. The historical stock price performance of our common stock
    shown is not necessarily indicative of future stock price performance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000041"
          xlink:label="Fact000041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000041"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000057"
          xlink:label="Fact000057"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000057"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000073"
          xlink:label="Fact000073"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000073"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnote id="Footnote000082" xlink:label="Footnote000082" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Pursuant to Item 402(v) of Regulation S-K, we determined our stock price to be the most important
    financial performance measure used to link Company performance to Compensation &#x201c;Actually Paid&#x201d; to our PEO and
    other NEOs in 2023. This performance measure may not have been the most important financial performance measure for prior
    years and we may determine a different financial performance measure to be the most important such measure in future years.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000045"
          xlink:label="Fact000045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000045"
          xlink:to="Footnote000082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000061"
          xlink:label="Fact000061"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000061"
          xlink:to="Footnote000082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000077"
          xlink:label="Fact000077"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000077"
          xlink:to="Footnote000082"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
